Robert J. Schmittling

3.2k citations

31 papers · 2.5k indexed · 1 hit paper · h-index 18

Co-authors: John H. Sampson Allan H. Friedman Roger E. McLendon Duane A. Mitchell James E. Herndon Gary E. Archer Darell D. Bigner Henry S. Friedman
Topics: Immunotherapy and Immune Responses (17 papers)Immune Cell Function and Interaction (9 papers)Cancer Immunotherapy and Biomarkers (9 papers)
Cited by: Genetics Immunology Oncology
Journals: Journal of Clinical Oncology Blood PLoS ONE
Partner nations: United States Australia United Kingdom

In The Last Decade

Robert J. Schmittling

31 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

2010 613 citations John H. Sampson, Amy B. Heimberger et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Robert J. Schmittling

Since Specialization

Citations

This map shows the geographic impact of Robert J. Schmittling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Schmittling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Schmittling more than expected).

Fields of papers citing papers by Robert J. Schmittling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Schmittling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Schmittling. The network helps show where Robert J. Schmittling may publish in the future.

Co-authorship network of co-authors of Robert J. Schmittling

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Schmittling. A scholar is included among the top collaborators of Robert J. Schmittling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Schmittling. Robert J. Schmittling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma 2018 ·Clinical Cancer Research ·Patrick C. Gedeon,Teilo Schaller,Satish K. Chitneni,Bryan D. Choi,Chien‐Tsun Kuan,Carter M. Suryadevara,David J. Snyder,Robert J. Schmittling,(unknown),Xiuyu Cui,Patrick Healy,James E. Herndon,Roger E. McLendon,Stephen T. Keir,Gary E. Archer,Elizabeth A. Reap,Luis Sánchez-Pérez,Darell D. Bigner,John H. Sampson	38
2	A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis 2018 ·Journal of Immunological Methods ·Adam M. Swartz,Elizabeth A. Reap,Pamela K. Norberg,Robert J. Schmittling,Sylvia Janetzki,Luis Sánchez-Pérez,John H. Sampson	5
3	Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination 2017 ·Clinical Cancer Research ·Kristen A. Batich,Elizabeth A. Reap,Gary E. Archer,Luis Sánchez-Pérez,Smita K. Nair,Robert J. Schmittling,(unknown),Weihua Xie,James E. Herndon,Patrick Healy,Roger E. McLendon,Allan H. Friedman,Henry S. Friedman,Darell D. Bigner,Gordana Vlahovic,Duane A. Mitchell,John H. Sampson	242
4	Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11) 2017 ·Cancer Immunology Immunotherapy ·Sridharan Gururangan,Elizabeth A. Reap,Robert J. Schmittling,Mehmet Koçak,Renée M. Reynolds,Gerald A. Grant,Arzu Onar‐Thomas,Patricia Baxter,Ian F. Pollack,Peter C. Phillips∥,James M. Boyett,Maryam Fouladi,Duane A. Mitchell	15
5	Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy 2016 ·Cancer Immunology Immunotherapy ·Anirudh Saraswathula,Elizabeth A. Reap,Bryan D. Choi,Robert J. Schmittling,Pamela K. Norberg,Elias Sayour,James E. Herndon,Patrick Healy,Kendra L. Congdon,Gerald E. Archer,Luis Sánchez-Pérez,John H. Sampson	6
6	Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma 2015 ·Journal of Neuro-Oncology ·Smita K. Nair,Timothy Driscoll,David Boczkowski,Robert J. Schmittling,Renée M. Reynolds,Laura A. Johnson,Gerald A. Grant,Herbert E. Fuchs,Darell D. Bigner,John H. Sampson,Sridharan Gururangan,Duane A. Mitchell	26
7	Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells 2014 ·Clinical Cancer Research ·Smita K. Nair,Gabriel De Leon,David Boczkowski,Robert J. Schmittling,Weihua Xie,Janet Staats,Rebecca Liu,Laura A. Johnson,Kent J. Weinhold,Gary E. Archer,John H. Sampson,Duane A. Mitchell	74
8	EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss 2013 ·Clinical Cancer Research ·John H. Sampson,Bryan D. Choi,Luis Sánchez-Pérez,Carter M. Suryadevara,David J. Snyder,Catherine Flores,Robert J. Schmittling,Smita K. Nair,Elizabeth A. Reap,Pamela K. Norberg,James E. Herndon,Chien-Tsun Kuan,Richard A. Morgan,Steven A. Rosenberg,Laura A. Johnson	241
9	BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide 2013 ·Cancer Immunology Immunotherapy ·Luis Sánchez-Pérez,Bryan D. Choi,Elizabeth A. Reap,Elias Sayour,Pamela K. Norberg,Robert J. Schmittling,Gerald E. Archer,James E. Herndon,Duane A. Mitchell,Amy B. Heimberger,Darell D. Bigner,John H. Sampson	13
10	Myeloablative Temozolomide Enhances CD8+ T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice 2013 ·PLoS ONE ·Luis Sánchez-Pérez,Bryan D. Choi,Gary E. Archer,Xiuyu Cui,Catherine Flores,Laura A. Johnson,Robert J. Schmittling,David J. Snyder,James E. Herndon,Darell D. Bigner,Duane A. Mitchell,John H. Sampson	52
11	A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma 2012 ·PLoS ONE ·John H. Sampson,Robert J. Schmittling,Gary E. Archer,Kendra L. Congdon,Smita K. Nair,Elizabeth A. Reap,Annick Desjardins,Allan H. Friedman,Henry S. Friedman,James E. Herndon,April Coan,Roger E. McLendon,David A. Reardon,James J. Vredenburgh,Darell D. Bigner,Duane A. Mitchell	91
12	Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastomabreakdown → 2010 ·Journal of Clinical Oncology ·John H. Sampson,Amy B. Heimberger,Gary E. Archer,Kenneth Aldape,Allan H. Friedman,Henry S. Friedman,Mark R. Gilbert,James E. Herndon,Roger E. McLendon,Duane A. Mitchell,David A. Reardon,Raymond Sawaya,Robert J. Schmittling,Weiming Shi,James J. Vredenburgh,Darell D. Bigner	613
13	Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines 2008 ·Journal of Immunological Methods ·Robert J. Schmittling,Gary E. Archer,Duane A. Mitchell,Amy B. Heimberger,Charles N. Pegram,James E. Herndon,Henry S. Friedman,Darell D. Bigner,John H. Sampson	41
14	Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma 2007 ·Neuro-Oncology ·Duane A. Mitchell,Weihua Xie,Robert J. Schmittling,Chris A. Learn,Allan H. Friedman,Roger E. McLendon,John H. Sampson	311
15	Genetic analysis of intracranial tumors in a murine model of glioma demonstrate a shift in gene expression in response to host immunity 2006 ·Journal of Neuroimmunology ·Chris A. Learn,Peter M. Grossi,Robert J. Schmittling,Weihua Xie,Duane A. Mitchell,Isaac O. Karikari,Zhengzheng Wei,Holly K. Dressman,John H. Sampson	6
16	Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma 2002 ·Biology of Blood and Marrow Transplantation ·Iain J. Webb,Jonathan W. Friedberg,John G. Gribben,David C. Fisher,Thomas R. Spitzer,Donna Neuberg,(unknown),Helen Kim,(unknown),(unknown),Robert J. Schmittling,Arnold S. Freedman	7
17	Expression of proliferation‐associated antigens (PCNA, p120, p145) during the reentry of G₀ cells into the cell cycle 1994 ·Cytometry ·Wade E. Bolton,James W. Freeman,(unknown),Cynthia G. Healy,Robert J. Schmittling,Norma S. Kenyon	29
18	Enhanced assessment of DNA/proliferative index by depletion of tumor infiltrating leukocytes prior to monoclonal antibody gated analysis of tumor cell DNA 1994 ·Cytometry ·Norma S. Kenyon,Robert J. Schmittling,Olavi Siiman,(unknown),Wade E. Bolton	3
19	Depletion of Infiltrating Leukocytes and Identification of Normal Fibroblasts prior to the Proliferative Assessment of Rare Event Tumor Cells 1993 ·Annals of the New York Academy of Sciences ·Robert J. Schmittling,Olavi Siiman,Norma S. Kenyon,Wade E. Bolton	1
20	Expression of proliferation associated antigens in the cell cycle of synchronized mammalian cells 1992 ·Cytometry ·Wade E. Bolton,(unknown),Cynthia G. Healy,Robert J. Schmittling,Norma S. Kenyon	55

About Robert J. Schmittling

Robert J. Schmittling is a scholar working on Immunology, Oncology and Genetics, having authored 31 papers that have together received 2.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (9 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Genetics (1.0k citations), Immunology (1.3k citations) and Oncology (1.4k citations). Robert J. Schmittling has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include John H. Sampson, Allan H. Friedman, Roger E. McLendon, Duane A. Mitchell, James E. Herndon, Gary E. Archer, Darell D. Bigner, Henry S. Friedman, Weihua Xie and Amy B. Heimberger. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact